Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

Clinical trial NCT02149303 · COMPLETED

Trial details

NCT number: NCT02149303
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation Hemorrhage

Start date: 2014-06-01
Primary completion: 2015-03-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.